On October 18th, 2021, QSI and TargetingOne build a joint research and development center for agricultural nucleic acid detection technology
Read moreOn August 31st, 2021, Beijing TargetingOne Technology Co., Ltd. launched a new coronavirus (SARS-CoV-2) antigen test kit and a new coronavirus/Influenza A/B virus antigen test kit with CE market access qualification.
Read moreRecently, the whole chain of novel coronavirus nucleic acid detection products developed by TargetingOne has been granted CE market access in the European Union.
Read moreThe evaluation of vaccines requires sensitive detection and quality control methods. Digital PCR technology becomes a powerful tool for vaccine development due to its advantages of high sensitivity, accuracy, quantification and inhibitor tolerance.
Read more